Delzicol and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Delzicol (mesalamine), especially for people who are female, 60+ old, also take Humira, and have Crohn's disease.

The phase IV clinical study analyzes which people have Rashes when taking Delzicol. It is created by eHealthMe based on reports of 879 people who have side effects when taking Delzicol from the FDA, and is updated regularly.

What is Delzicol?

Delzicol has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 894 Delzicol users. Check the latest studies of Delzicol.

What is Rashes?

Rashes (redness) is found to be associated with 3,713 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 16, 2026

879 people reported to have side effects when taking Delzicol.
Among them, 30 people (3.41%) have Rashes.

Among these 30 people:

What is the gender of people who have Rashes when taking Delzicol? *

female: 72.41 %
male: 27.59 %

What is the age of people who have Rashes when taking Delzicol? *

What are other drugs people take besides Delzicol? *

What are other side effects people have besides Rashes? *

Itching: 6 people, 20.00%
Diarrhea: 6 people, 20.00%
Drug Ineffective: 5 people, 16.67%
Nausea (feeling of having an urge to vomit): 4 people, 13.33%
Abdominal Pain: 4 people, 13.33%
Skin Exfoliation (removal of the oldest dead skin cells): 4 people, 13.33%
Hypersensitivity: 3 people, 10.00%
Bowel Movement Irregularity: 3 people, 10.00%
Dry Skin: 3 people, 10.00%
Nausea And Vomiting: 3 people, 10.00%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 23.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.00%
Hypersensitivity: 2 people, 6.67%
High Blood Pressure: 2 people, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.67%
Depression: 2 people, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%
High Blood Cholesterol: 2 people, 6.67%
Colitis (inflammation of colon): 1 person, 3.33%
Dry Mouth: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Delzicol and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Delzicol:

Delzicol (894 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Delzicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,713 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,213 conditions)

Related publications that referenced our studies

Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on mesalamine (the active ingredients of Delzicol) and Delzicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.